FVFRX
Price
$58.67
Change
-$2.47 (-4.04%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

FVFRX vs VSIAX

Header iconFVFRX vs VSIAX Comparison
Open Charts FVFRX vs VSIAXBanner chart's image
Franklin Small Cap Value R
Price$58.67
Change-$2.47 (-4.04%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
FVFRX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FVFRX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FVFRX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. FVFRX (4.27B). VSIAX pays higher dividends than FVFRX: VSIAX (2.01) vs FVFRX (0.55). FVFRX was incepted earlier than VSIAX: FVFRX (22 years) vs VSIAX (13 years). FVFRX is a more actively managed with annual turnover of: 68.74 vs. VSIAX (16.00). FVFRX has a lower initial minimum investment than VSIAX: FVFRX (1000) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. FVFRX (12.21). VSIAX return over 5 years is better than : 52.83 vs. FVFRX (27.72).
FVFRXVSIAXFVFRX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence22 years13 years-
Gain YTD15.22815.031101%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets4.27B63B7%
Annual Yield % from dividends0.552.0127%
Returns for 1 year12.2116.2375%
Returns for 3 years13.7720.6767%
Returns for 5 years27.7252.8352%
Returns for 10 years17.61105.6517%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics